skip to main content

brainstorm askiatroX medicines

simulations beta

loading page…

learn & practise

exams international doctors free questions Socratic Tutor rounds stat clinical connections academy journal tool guides

clinical reference

askiatroX knowledge centre medicines UK / NICE guidance international guidance calculators q&a library

trust & support

how it works methodology account & support frequently asked questions about us clinical safety consultancy

legal

mobile app · scan to download

Medicines tafasitamabQuestion & answer

tafasitamab · Medicine question

Does tafasitamab increase infection risk?

iatroX medicinesPublished 21 August 2026Reviewed 21 August 2026

The answer

Answer

Yes. It can reduce blood cells and B cells, and serious or opportunistic infections have occurred.

Sources for this answer

MINJUVI 200 mg powder for concentrate for solution for infusionemc · SmPC Current selected SmPC · Version 13

Explore this learning need in CPDTake this topic to CPD, then choose your learning context and available question library.

The full medicine guide

tafasitamab

Read the wider context, including uses, precautions and the sources behind this medicine guide.

Read the tafasitamab guide

More questions about tafasitamab

Is tafasitamab chemotherapy?Which cancers is tafasitamab licensed to treat in the UK?How is tafasitamab given?Can I have vaccines while receiving tafasitamab?What monitoring is needed with tafasitamab?Can children receive tafasitamab?

More clinical questions?

Explore the tools and reference material available on iatroX.

Explore askiatroX